Literature DB >> 19258940

Class II radical hysterectomy in low-risk IB squamous cell carcinoma of cervix: a safe and effective option.

Hong-Bing Cai1, Hui-Zhen Chen, Yun-Feng Zhou, Dao-Mei Lie, Han-Yin Hou.   

Abstract

UNLABELLED: The aim of this study was to determine the outcome of class II radical hysterectomy for the treatment of a subset of patients with early cervical cancer.
METHOD: From September 1995 to September 2003, a total of 480 patients whose conditions were diagnosed with squamous carcinoma of the cervix with a tumor size of no greater than 2 cm and a pathological grade 1 to 2 was enrolled in a cohort study to compare class II and class III radical hysterectomy, with 240 patients in each group. Disease-free survival, overall survival, pattern of recurrences, and morbidity were the end points of observation for this study.
RESULTS: The class II surgery group had 100.0% overall and 98.33% disease-free actuarial 5-year survival rate, whereas the class III surgery group had 100.0% overall and 97.92% disease-free actuarial 5-year survival rate (P = 0.736). Recurrence rate (2.92% in class II vs 2.50% in class III) was not significantly different in the 2 groups (P = 0.779). The operating time, postoperative length of hospital stay, and estimated blood loss at surgery were significantly lower in the group of patients who underwent class II hysterectomy (P = 0.0001, P = 0.0001, and P = 0.001, respectively). The postoperative complications were also significantly lower in patients who received class II hysterectomy.
CONCLUSIONS: In treating a subset of patients with tumor size no greater than 2 cm and grade 1 to 2 squamous cell cancer, class II and class III radical hysterectomy are equally effective, but the former has far less complications than the latter.

Entities:  

Mesh:

Year:  2009        PMID: 19258940     DOI: 10.1111/IGC.0b013e318197f847

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  [Protective effects of hydrogen-rich medium on lipopolysaccharides-induced injury in human periodontal ligament cells].

Authors:  Min Zhou; Zuo-Lin Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-04-01

2.  To what extent should we perform parametrectomy in FIGO stage IB cervical cancer?

Authors:  Ali Ayhan; Eralp Başer; Polat Dursun; Asuman Nihan Haberal
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-06-01

3.  Treatment and Outcomes of Early and Operable Recurrent Cervical Cancer: A Prospective Study.

Authors:  Nikhil Mehta; Sanjay M Desai; Vinod Dhakad; Dhruv Patel; Elroy Saldanha
Journal:  Niger J Surg       Date:  2021-03-09

4.  Radical hysterectomy with pelvic lymphadenectomy: indications, technique, and complications.

Authors:  Rachel A Ware; John R van Nagell
Journal:  Obstet Gynecol Int       Date:  2010-09-01

5.  Postoperative surgical complications of lymphadenohysterocolpectomy.

Authors:  F Marin; M Pleşca; C I Bordea; S C Voinea; I Burlănescu; E Ichim; C G Jianu; R R Nicolăescu; M P Teodosie; K Maher; A Blidaru
Journal:  J Med Life       Date:  2014-03-25

6.  Narrowing Resection of Parametrial Tissues Is Feasible in Low-Risk Cases of Stage IA2-IB1 Cervical Cancer.

Authors:  Xue-Lian Li; Xiao-Xia Liu; Guan-Shu Cao; Dan-Dan Ju; Hua Jiang
Journal:  J Cancer       Date:  2016-07-05       Impact factor: 4.207

7.  Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis.

Authors:  Emma R Allanson; Aime Powell; Max Bulsara; Hong Lim Lee; Lynette Denny; Yee Leung; Paul Cohen
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

8.  Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer.

Authors:  Chunlin Chen; Wuliang Wang; Ping Liu; Pengfei Li; Lu Wang; Shuangling Jin; Xiaonong Bin; Jinghe Lang
Journal:  Cancer Manag Res       Date:  2019-12-31       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.